Funny how Verdezyne had a adipic acid program which Bioamber has even referenced in patent filings... Key investors (DSM) in Verdezyne made a business decision to wind up Verdezyne May 2018...
CEO of Verdezyne incorporates a Delaware corporation June 2018.... It went by Vertubio
Verdezyne IP and General Counsel decided to also be part of Vertubio....
Vertubio setup their headquarters mere blocks from Verdezyne office....
Erik Rutten who now works for Visolis was once on the BOD of Verdezyne when he worked for DSM...
Now Visolis magically takes over the research project with the University of Toronto on adipic acid.... Bioamber contributed over $1 million to that research project
DSM was included on the Bioamber CCAA service list represented by Luc Morin during the initial Sisp... Vertubio was also created during this period of June 2018...
DSM was removed from the service list and replaced with the Purchaser of the APA following court approval and represented by Luc Morin!!
The Ceo of Verdezyne who created Vertubio which recently changed its name is now the CEO of LCY Biosciences....